Inhibition of glycolysis by 2-DG reversed the effect of FOXD1 overexpression on hypoxia-induced prostate cancer cell growth, implying the FOXD1 exerted its roles via regulating glycolysis. The gene discussed is FOXD1; the disease is prostate cancer.